Theradiag SA
EPA:ALTER.PA
1.26 (EUR) • At close December 15, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Theradiag SA |
Symbool | ALTER.PA |
Munteenheid | EUR |
Prijs | 1.26 |
Beurswaarde | 17,291,358 |
Dividendpercentage | 0% |
52-weken bereik | 1.18 - 2.39 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Simon Daviere |
Website | https://www.theradiag.com |
An error occurred while fetching data.
Over Theradiag SA
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)